LC
PFE icon

Lavaca Capital’s Pfizer PFE Stock Holding History

Lavaca Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$316K Buy
11,267
+639
+6% +$17K 0.06% 85
2025
Q4 		$265K Buy
10,628
+1,267
+14% +$32K 0.04% 90
2025
Q3 		$239K Buy
9,361
+20
+0.2% +$494 0.04% 94
2025
Q2 		$226K Buy
9,341
+20
+0.2% +$466 0.08% 97
2025
Q1 		$236K Sell
9,321
-182
-2% -$4.76K 0.1% 93
2024
Q4 		$252K Sell
9,503
-2,477
-21% -$67.2K 0.1% 104
2024
Q3 		$347K Buy
11,980
+416
+4% +$12.1K 0.15% 82
2024
Q2 		$324K Buy
11,564
+316
+3% +$8.7K 0.17% 68
2024
Q1 		$312K Buy
11,248
+601
+6% +$16.7K 0.18% 65
2023
Q4 		$307K Sell
10,647
-3,240
-23% -$97.9K 0.17% 74
2023
Q3 		$461K Sell
13,887
-710
-5% -$25.1K 0.15% 102
2023
Q2 		$535K Sell
14,597
-11,451
-44% -$446K 0.16% 105
2023
Q1 		$1.11M Buy
26,048
+241
+0.9% +$10.4K 0.23% 69
2022
Q4 		$1.26M Buy
25,807
+10,605
+70% +$508K 0.39% 56
2022
Q3 		$760K Buy
15,202
+8
+0.1% +$389 0.27% 82
2022
Q2 		$750K Buy
15,194
+8
+0.1% +$408 0.11% 108
2022
Q1 		$786K Sell
15,186
-21,125
-58% -$1.1M 0.08% 130
2021
Q4 		$2.14M Sell
36,311
-6,900
-16% -$342K 0.28% 37
2021
Q3 		$1.86M Sell
43,211
-2,275
-5% -$101K 0.19% 36
2021
Q2 		$1.78M Sell
45,486
-21,984
-33% -$855K 0.18% 33
2021
Q1 		$2.44M Buy
67,470
+12,378
+22% +$439K 0.21% 23
2020
Q4 		$2.03M Buy
55,092
+15,138
+38% +$555K 0.27% 26
2020
Q3 		$1.39M Buy
39,954
+5,933
+17% +$208K 0.22% 35
2020
Q2 		$1.05M Buy
34,021
+5,042
+17% +$171K 0.34% 35
2020
Q1 		$897K Hold
28,979
– – 0.87% 26
2019
Q4 		$1.08M Hold
28,979
– – 0.83% 28
2019
Q3 		$988K Hold
28,979
– – 0.75% 33
2019
Q2 		$1.19M Sell
28,979
-527
-2% -$20.9K 0.92% 28
2019
Q1 		$1.19M Hold
29,506
– – 1.01% 25
2018
Q4 		$1.22M Buy
+29,506
New +$1.22M 1.22% 22

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lavaca Capital's PFE Position: Q1 2026 in Review

Lavaca Capital increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $17K and bringing the position to 11,267 shares worth $316K. The position accounts for 0.06% of the portfolio, ranked #85.

Lavaca Capital first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.44M in Q1 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Lavaca Capital held 11,267 shares of Pfizer worth $316K as of Q1 2026.
  • Lavaca Capital bought 639 Pfizer shares in Q1 2026, an estimated $17K.
  • Pfizer made up 0.06% of Lavaca Capital's portfolio in Q1 2026, its #85 holding.
  • Lavaca Capital first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Lavaca Capital's Pfizer position peaked at $2.44M in Q1 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.